Dr. Nita Patel is a vaccinologist and biotechnology leader best known for leading development of the Novavax COVID-19 vaccine. At Novavax, she directed a predominantly female research team that developed a protein-based vaccine platform, providing an alternative to mRNA vaccines during the global pandemic. Over a career spanning decades, Patel has contributed to the development of vaccines for a range of infectious diseases, helping advance public health and pandemic preparedness. Her work has played an important role in expanding vaccine technologies and improving access to life-saving immunizations worldwide.